Estimation of the attributable burden of colorectal cancer in Iran in 2008

Iranian Journal of Epidemiology

Volumn 9, Issue 4, 2014, Pages 1-9

  Mahmoudlou, A ^a   Yavari, P ^b   Abolhasani, F ^b   Khosravi, A ^c   Ramazani, R ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Colorectal cancer; DALY; Disease burden

Indexed keywords

ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; DISABILITY ADJUSTED LIFE YEAR; DISEASE DURATION; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; YEARS LIVED WITH DISABILITY; YEARS OF LIFE LOST; DISABILITY;

EID: 84929392661     PISSN: 17357489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. World Health Organization, How is Public Interest Protected, in World Health Report 2000. Health system: Improving Performance, 2000.
2. Murray CJL. AcharyaAk, Understanding DALYs. J Health Econ 1997;16:103-30.
3. Naghavi M, Abolhassani F, Moradi Lake M, Jafari N, Shoaaee SH, Vosughi S, et al. National burden of disease Studies: A Practical guide for National and Provincial Level. Ministry of Heath, Treatment and Medical education, Tehran 2005.
4. Murray CJL, Lopez AD. The Global burden of disease: A Comprehensive Assessment of Mortality and disability form diseases, injuries and risk factors in 1990 and projected to 2020.
5. Global burden of disease and Injury Series. Gold man L, Austell D. Cecil Textbook of Medicine, 22th Edition, WB Saunders Company: USA, 2003, Harvard University Press.
6. Naghavi M, Abolhassani F. Moradi Lake M, Disease burden in three Provinces of IRAN, Western Azerbaijan, Booshehr and Charmahale Bakhtiari 2001. Ministry of Health, Treatment and Medical education, Tehran 2003.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; (2010)). Available from: http://globocan.iarc.fr. [Last accessed on 2012 July 22].
8. Foroutan M, Rahimi N, Tabatabaeifar M, Darvishi M, Hashemi M, Hossein-Panah F, Zali MR. Clinical features ofcolorectal cancer in Iran: a 15-year review J Dig Dis. 2008 4: 225-7
9. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, Fakheri H, Semnani S, Arshi S, Zahedi MJ, Darvish-Moghadam S, Mansour-Ghanaei F, Mosavi A, Malekzadeh R. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry, Cancer Letter. 2006 Aug 18; 240: 143-7. Epub 2005.
10. Isabelle Soerjomataram, Melissa S. Y. Thong, Majid Ezzati, Elizabeth B. Lamont, Wilma J. Nusselder, Lonneke V. van de Poll-Franse, Most colorectal cancer survivors live a large proportion of their remaining life in good health, Cancer Causes Control 2012, 23: 1421-8.
11. Ardeshir Khosravi, Richard Taylor, Mohsen Naghavi & Alan D Lopeza, Mortality in the Islamic Republic of Iran, 1964-2004, Bulletin of the World Health Organization 2007; 85: 607-614.
12. Rashidian A, Khosravi A, Arab M, Beheshtian M, Khabiri R, Karimi A. I.R. Iran Multiple-Indicator Demographic and Health Survey 2010. Deputy for Health Ministry of Health and Medical Education.
13. Ministry of Health, Treatment and Medical education, National burden of disease and injuries in IRAN, 2007, Tehran 2007.
14. Stouthard MEA, Essink -Bot ML, Bonsel GJ, On behalf of the Dutch Disability Weights Group. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health. 2000; 10: 24-30.
15. Moradi A, Khayamzadeh M, Guya MM, Mirzaei HR, Salmanian R, Rakhsha A, Akbari ME. Survival of colorectal cancer in Iran. Asian Pacific Journal of Cancer Prevention. 2009 Oct-Dec; 10: 583-6.
16. Moghimi-Dehkordi B, Safaee A, Zali MR. Comparison of colorectal and gastric cancer: survival and prognostic factors. Saudi Journal of Gastroenterology. 2009 Jan; 15: 18-23
17. Hoseini Nasab A, Modir A, Shiryazdi M. Survival of colorectal cancer patients in Yazd. Journal of Shahid Sadoghi University of Medical Sciences 2000; 9(4); 24-29.
18. Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, Fatemi SR. Recognition of the factors affecting survival in colon and rectal cancer patients referred to RCGLD center of Shahid Beheshti University of Medical Sciences: accelerated failure time parametric survival analysis with frailty. Journal of Sharekord University of Medical Sciences 2010; 22(2): 51-64.
19. Aryaie M, A survey of survival rate in colorectal cancer patients in Golestan province,2011, submitted in partial fulfillment of the requirements for degree of master of science.
20. Centers for Disease Control and Prevention. (2009). United States cancer statistics. From the centers for disease control and prevention website: http://apps.nccd.cdc.gov/uscs/Table.aspx?Group=3f&Year
21. Mehrkhani F, Nasiri S, Donboli K, Meysami A, Hedayat A.(2009). Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis 2009; 11: 157-161
22. Ghazali AK, Musa KI, Naing NN, Mahmood Z. Prognostic factors in patients with colorectal cancer at Hospital University Sains Malaysia. Asian J Surg; 2010; 33: 127-133.
23. Chu, D. Z. (2007). Cancer recurrence and survival associated with dietary patterns in stage III colon cancer. Jama, 298(19), 2263; author reply 2263.
24. Benson AB, Schrag D, Somer and MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clinic Oncology 2004; 22: 3408-19.
25. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, Fluorouracil, and Leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-51.
26. Hawk ET, Umar A, Viner JL. Colorectal Cancer Chemoprevention: an overview of the science. Gastroenterology 2004; 126: 1423-47.
27. Reichmann C, Sargent DJ. New treatment options for colorectal cancer. N Engl J Med 2004; 351: 391-92
28. Van Custom, Dicato M, Wills J, et al. Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, Eur J Cancer 2002;38:1429-36.
29. Liobera J, Esteva M, et al.(2000). Terminal cancer: duration and prediction of survival time. European Journal ofCancer,36,2036-2043
30. Morris JN, Suissa S, Sherwood S, Wright SM, Greer D. Last days: a study of the quality of life of terminally ill patients. J Chron Dis,1986,39,47-62
31. Vigano A, Bruera E, Suarez-Almanzor ME. Terminal cancer syndrome: myth or reality? J Palliat Care 1999, 15, 32-39.
32. Coale A, Demeny P, Vaughan B. Regional model life tables and stable populations. 2nd ed. New York (NY): Academic Press; 1983.
33. World Health Organization. The global burden of disease: 2004 update. Geneva, World Health Organization,2008. Available at http://www.who.int/evidence/bod.
34. National report of cancer registration in Iran. Ministry of health, treatment and Medical education, Tehran 2003- 2007.
35. Safaei A, Moghimi Dehkordy B, Fatemi SR, Zali MR. Epidemiology of colorectal cancer: Study the recorded cases in 1998-2009. Tbib-e-Shargh J. 2007; 9: 209-17.
36. Emami MH, Fatemi AM, Farajzadegan Z, Movahed Abtahi SM. Epidemiology of colorectal cancer in Isfahan. Govaresh. 2005; 10: 134-9.